1. Home
  2. NSSC vs EVO Comparison

NSSC vs EVO Comparison

Compare NSSC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

SELL

Current Price

$35.32

Market Cap

1.3B

ML Signal

SELL

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.40

Market Cap

568.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
EVO
Founded
1969
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
568.6M
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
NSSC
EVO
Price
$35.32
$1.40
Analyst Decision
Strong Buy
Buy
Analyst Count
6
3
Target Price
★ $50.67
$4.24
AVG Volume (30 Days)
★ 271.9K
168.9K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
★ 1.89%
N/A
EPS Growth
★ 0.84
N/A
EPS
★ 1.20
N/A
Revenue
★ $202,316,000.00
N/A
Revenue This Year
$8.29
N/A
Revenue Next Year
$8.54
$20.47
P/E Ratio
$29.97
★ N/A
Revenue Growth
★ 11.39
N/A
52 Week Low
$33.91
$1.33
52 Week High
$51.77
$4.27

Technical Indicators

Market Signals
Indicator
NSSC
EVO
Relative Strength Index (RSI) 45.10 33.57
Support Level $34.51 N/A
Resistance Level $37.00 $1.97
Average True Range (ATR) 0.84 0.06
MACD 0.01 -0.01
Stochastic Oscillator 33.17 16.25

Price Performance

Historical Comparison
NSSC
EVO

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc develops, manufactures, and distributes security products, including access control systems, door security products, intrusion and fire alarm systems, alarm communication services, and video surveillance products for commercial and residential use. The Company also provides wireless communication services for intrusion and fire alarm systems. Its products include Intrusion and Access Alarm Products, Door Locking Devices and Services. The products are used for commercial, residential, institutional, industrial and governmental applications and are sold principally to independent distributors, dealers and installers of security equipment. The Company generates maximum revenue from the United States.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: